CRSP - Crispr Therapeutics AG - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CRSP is currently covered by 14 analysts with an average price target of $72.14. This is a potential upside of $21.12 (39.19%) from yesterday's end of day stock price of $51.83.

Crispr Therapeutics AG's activity chart (see below) currently has 325 price targets and 255 ratings on display. The stock rating distribution of CRSP is 77.27% BUY and 22.73% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 66.02% with an average time for these price targets to be met of 104.52 days.

Highest price target for CRSP is $110, Lowest price target is $44, average price target is $72.14.

Most recent stock forecast was given by GIL BLUM from NEEDHAM on 31-Aug-2026. First documented stock forecast 14-Nov-2016.

Best performing analysts who are covering CRSP - Crispr Therapeutics AG:

Joon Lee James Lee Edward Tenthoff Gil Blum Salim Syed Kostas Biliouris

Currently out of the existing stock ratings of CRSP, 17 are a BUY (77.27%), 5 are a HOLD (22.73%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 16-Feb-2022

$82

$30.28 (58.55%)

$82

16 days ago
(31-Aug-2026)

8/28 (28.57%)

$25.02 (43.91%)

214

Buy Since 18-Apr-2024

$88

$36.28 (70.15%)

$82

1 months 12 days ago
(04-Aug-2026)

10/20 (50%)

$34.93 (65.82%)

160

Hold Since 11-Jun-2026

$60

$5.08 (9.25%)

$32

3 months 5 days ago
(11-Jun-2026)

8/9 (88.89%)

$9.77 (19.45%)

254

Buy Since 17-Jan-2018

$110

$55.08 (100.29%)

$105

5 months 30 days ago
(17-Mar-2026)

27/36 (75%)

$59.91 (119.60%)

235

Buy Since 28-Oct-2019

$76

$21.08 (38.38%)

$74

6 months 30 days ago
(17-Feb-2026)

2/16 (12.5%)

$22.83 (42.94%)

24

Show more analysts

Please expand the browser size to see the chart

What is CRSP (Crispr Therapeutics AG) average time for price targets to be met?

On average it took 105 days for the stock forecasts to be reached, with an average price target met ratio of 66.02%.

Which analyst most recently updated their price target on CRSP (Crispr Therapeutics AG)?

Gil Blum

Which analyst has the most public recommendations on CRSP (Crispr Therapeutics AG)?

Gil Blum works at NEEDHAM and has 6 price targets and 4 ratings on CRSP

Which analyst is the currently most bullish on CRSP (Crispr Therapeutics AG)?

Tony Butler with the highest potential upside of $116.01

Which analyst is the currently most reserved on CRSP (Crispr Therapeutics AG)?

William Pickering with the lowest potential downside of -$13.92

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?